We speak to Professor Begoña Calvo to find out more about her research into pharmaco vigilance for biosimilars.

The first US biosimilar has been pocketed and the game is on. We bring six experts to the table to discuss the impact on industry dynamics.

$100 million pledged to kick start investment in new research

FDA scolds company for revealing interim trial results

Just how prevalent is pharmacogenomic information on European drug labels?

New technology interprets slang and banter to find out what people really think

An antimalarial medicine-making project wins the inaugural Humanity in Science Award.

Information from “stalled” drug trials should be published, not tossed aside

Global healthcare company GlaxoSmithKline (GSK) has pledged to be carbon neutral by 2050.

A ‘robot scientist’, capable of independently carrying out drug screening research, has been developed by UK researchers.